Oorsprong van het eerstegraads netwerk van Karen McTavish
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
| Subsidiary | Biotechnology | 18 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Karen McTavish via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| McGill University | College/University | Masters Business Admin Masters Business Admin Graduate Degree Graduate Degree | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| University of Montréal | College/University | Doctorate Degree Doctorate Degree Doctorate Degree | |
American Society of Clinical Oncology, Inc.
 American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services The American Society of Clinical Oncology is a non-profit organization founded in 1964 with the overarching goals of improving cancer care and prevention. More than 27,000 oncology practitioners belong to ASCO, representing all oncology disciplines and subspecialties. Members include physicians and health-care professionals in all levels of the practice of oncology. American Society of Clinical Oncology is the world’s leading professional organization representing physicians who treat people with cancer. ASCO’s members set the standard for patient care worldwide and lead the way in carrying out clinical research aimed at improving the prevention, diagnosis, and treatment of cancer. ASCO's efforts are also directed toward advocating for policies that provide access to high-quality care for all patients with cancer and at supporting the increased funding for clinical and translational research. | Medical/Nursing Services | Corporate Officer/Principal Corporate Officer/Principal | |
| OCERA THERAPEUTICS INC | Pharmaceuticals: Major | Director/Board Member Chairman | |
| University of Michigan | College/University | Undergraduate Degree Doctorate Degree | |
Yuma Therapeutics Corp.
 Yuma Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Yuma Therapeutics Corp. operates as a biopharmaceutical company. It develops novel disease-modifying small molecule compounds that modulate cellular proteostasis to treat neurodegenerative proteinopathies. The company was founded by Yukari Y. Perrella and Martin D. Williams in 2009 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member | |
| Union College (New York) | College/University | Undergraduate Degree | |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Masters Business Admin | |
Schering-Plough Corp.
 Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
eMedguides.com, Inc.
 eMedguides.com, Inc. Internet Software/ServicesTechnology Services eMedguides.com, Inc. provides an online and in-print internet directory for medical professionals. The company was founded by Daniel Goldenson and Raymond C. Egan and is headquartered in Princeton, NJ. | Internet Software/Services | Founder | |
| Mead Johnson International Ltd. | President | ||
| Bristol Laboratories, Inc. | President | ||
| Trinity College (Connecticut) | College/University | Undergraduate Degree | |
| Syracuse University | College/University | Masters Business Admin | |
Fonds de Solidarité FTQ
 Fonds de Solidarité FTQ Investment ManagersFinance Fonds de Solidarité FTQ (Fonds Régional de Solidarité FTQ) is a private equity firm founded in June 1983. The firm is headquartered in Montréal, Quebec. | Investment Managers | Private Equity Investor | |
| NEPTUNE WELLNESS SOLUTIONS INC. | Pharmaceuticals: Other | Public Communications Contact | |
| BETTERLIFE PHARMA INC. | Pharmaceuticals: Major | Chief Executive Officer | |
Jubilant Draximage, Inc.
 Jubilant Draximage, Inc. Pharmaceuticals: MajorHealth Technology Jubilant DraxImage, Inc. engages in the provision of development, manufacturing, and commercialization of radiopharmaceuticals. Its product Drax Exametazime used for the diagnosis and treatment of disease such as intra-abdominal infection and inflammatory bowel disease. The company is headquartered in Kirkland, Canada. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| BIOSYNTECH, INC. | Pharmaceuticals: Major | Chairman | |
| EDGEWISE THERAPEUTICS, INC. | Biotechnology | Founder | |
| CORVUS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Founder | |
| PMV PHARMACEUTICALS, INC. | Miscellaneous Commercial Services | Director/Board Member | |
| ALPINE IMMUNE SCIENCES, INC. | Biotechnology | Director/Board Member | |
OxOnc Development LP
 OxOnc Development LP BiotechnologyHealth Technology OxOnc Development LP operates as an oncology development company. It offers a drug development model that is based on the expertise and core competencies to design and execute clinical trials in oncology. The firm's business model is an integration of scientific, clinical, operational and financial resources, and provides a value-add proposition to its co-development partner by providing a profit and loss-sparing mechanism to fund research and development efforts externally. The company was founded in 2012 and is headquartered in George Town, Cayman Islands. | Biotechnology | Director/Board Member | |
| SYNTHORX, INC. | Biotechnology | Director/Board Member | |
| The Warren Alpert Medical School | College/University | Doctorate Degree | |
| PREVAIL THERAPEUTICS INC. | Biotechnology | Director/Board Member | |
Angel Pharmaceuticals Co., Ltd.
 Angel Pharmaceuticals Co., Ltd. BiotechnologyHealth Technology Angel Pharmaceuticals Co., Ltd. operates as a biopharmaceutical company which develops medicines for treatment of cancer, autoimmune and infectious diseases. The company was founded by Richard Miller and Ted Wang on October 5, 2020 and is headquartered in Shanghai, China. | Biotechnology | Director/Board Member | |
| MEDMIRA INC. | Medical Specialties | Director/Board Member | |
| DECIBEL THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
| JANUX THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
ReCode Therapeutics, Inc.
 ReCode Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ReCode Therapeutics, Inc. operates as a biopharmaceutical company. It develops precision medicines for pulmonary diseases. The company is headquartered in Irvin, TX. | Pharmaceuticals: Major | Director/Board Member | |
Gennao Bio, Inc.
 Gennao Bio, Inc. Pharmaceuticals: MajorHealth Technology Gennao Bio, Inc. is a privately-held genetic medicines company that is developing first-in-class, non-viral, targeted nucleic acid therapeutics utilizing its proprietary gene monoclonal antibody (gmab) platform technology. The company is based in Pennington, NJ. The company's gmab technology uses a novel, cell-penetrating antibody to non-covalently bind to, and deliver therapeutic levels of a wide variety of nucleic acid payloads, to select cells. Gennao Bio is initially focusing on addressing significant unmet needs in oncology and rare monogenic skeletal muscle diseases. The company's non-viral delivery platform offers significant advantages over traditional gene delivery systems as it can deliver multiple types of nucleic acids, allows for repeat dosing and dose optimization, and can be easily and affordably manufactured. The company was founded in 2020 by Bruce Turner, Elias Quijano, Peter M. Glazer, Stephen P. Squinto. Christopher M. Duke has been the CEO of the company since 2021. | Pharmaceuticals: Major | Director/Board Member | |
Terremoto Biosciences, Inc.
 Terremoto Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Terremoto Biosciences, Inc. is a drug discovery and development company that creates highly targeted, small molecule medicines with unmatched selectivity, potency, and efficacy to deliver superior therapeutic benefit to patients. The company is based in San Francisco, CA. Terremoto is supported by leading investors, including OrbiMed, Third Rock Ventures, EcoR1 Capital, Novo Holdings, and Cormorant Capital. The company aims to expand the universe of drug targets and improve existing medicines by unleashing the power of covalent chemistry. Terremoto was founded by Peter A. Thompson and Matthew P. Jacobson, and Peter A. Thompson has been the CEO since incorporation. | Pharmaceuticals: Major | Founder | |
| ARS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member |
Statistieken
Internationaal
| Verenigde Staten | 32 |
| Canada | 17 |
| Verenigd Koninkrijk | 2 |
| Kaaimaneilanden | 2 |
| China | 2 |
Sectoraal
| Health Technology | 36 |
| Consumer Services | 9 |
| Finance | 3 |
| Health Services | 2 |
| Technology Services | 2 |
Operationeel
| Director/Board Member | 104 |
| Corporate Officer/Principal | 55 |
| Independent Dir/Board Member | 32 |
| Chairman | 24 |
| President | 16 |
Sterkste connecties
| Insiders | |
|---|---|
| Peter Thompson | 39 |
| Louis P. Lacasse | 26 |
| David Drutz | 24 |
| Jay Moorin | 21 |
| Martin Godbout | 21 |
| Robert Martell | 18 |
| Joseph Walewicz | 15 |
| Toni Rinow | 14 |
| Colin R. Mallet | 12 |
| André Archimbaud | 10 |
| Donald F. Corcoran | 9 |
| Raymond C. Egan | 7 |
| Charles Grubsztajn | 7 |
| Daniel Delorme | 5 |
| Klaus B. Kepper | 4 |
- Beurs
- Insiders
- Karen McTavish
- Bedrijfsconnecties
